Statement of Organization, Functions, and Delegations of Authority, 19711 [2013-07582]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 63 / Tuesday, April 2, 2013 / Notices
health of American women by
advancing and coordinating a
comprehensive women’s health agenda
throughout HHS. The office fulfills its
mission by advancing policy and
issuing competitive contracts to an array
of community, academic, and other
organizations at the national and
community levels. In addition, OWH’s
national educational campaigns provide
information about the important steps
women can take to improve and
maintain their health, such as NWHW.
NWHW is a week-long health
observance that kicks off on Mother’s
Day, Sunday, May 12 and ends
Saturday, May 18, 2013. NWHW seeks
to educate women about improving
their physical and mental health and
preventing disease. More than 2,200
events were held nationwide in 2012.
Week-long, daily messages encourage
women to make their health a top
priority and take simple steps for a
longer, healthier, and happier life. For
more information about NWHW, please
visit https://womenshealth.gov/nwhw/.
Dated: March 27, 2013.
Nancy C. Lee,
Deputy Assistant Secretary for Health—
Women’s Health.
[FR Doc. 2013–07617 Filed 4–1–13; 8:45 am]
BILLING CODE 4150–33–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
srobinson on DSK4SPTVN1PROD with NOTICES
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 78 FR 5812, dated
January 28, 2013) is amended to reflect
the reorganization of the Office for State,
Tribal, Local, and Territorial Support.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete in its entirety the title and
function statements for the Knowledge
Management Office (CQA5), Office of
the Director (CQA).
Revise the functional statement for
the Public Health Law Office (CQA2),
Office of the Director (CQA) as follows:
After item (8), insert the following: (9)
establish collaboration and coordination
between clinical medicine and public
VerDate Mar<15>2010
19:35 Apr 01, 2013
Jkt 229001
health to better coordinate and partner
for healthier communities.
Dated: March 22, 2013.
Sherri A. Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2013–07582 Filed 4–1–13; 8:45 am]
BILLING CODE 4160–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 78 FR 5812, dated
January 28, 2013) is amended to reflect
the reorganization of the Office of the
Associate Director for Science, Office of
the Director, Centers for Disease Control
and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete in its entirety the title and
function statements for the Public
Health Prevention Service Branch
(CPLCC), Division of Leadership and
Practice (CPLP).
Dated: March 22, 2013.
Sherri A. Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2013–07545 Filed 4–1–13; 8:45 am]
BILLING CODE 4160–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–0338]
Center for Devices and Radiological
Health: Experiential Learning Program
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration’s (FDA) Center for
Devices and Radiological Health (CDRH
or Center) is announcing an invitation
for participation in its Experiential
Learning Program (ELP). The ELP
provides a formal training mechanism
SUMMARY:
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
19711
for regulatory review staff to visit
research, clinical, manufacturing, and
health care facilities to observe firsthand
how medical devices are designed,
developed, and utilized. This training is
intended to provide CDRH staff with an
opportunity to observe the device
development life cycle and provide a
better understanding of the medical
devices they review, and the challenges
faced throughout development, testing,
manufacturing, and clinical use. The
purpose of this document is to invite
medical device and health care facilities
to participate in this formal training
program for FDA’s medical device
review staff, or to contact CDRH for
more information regarding the
program.
DATES: Submit either an electronic or
written request for participation in this
program by May 2, 2013. The request
should include a description of your
facility relative to product areas CDRH
regulates. Please include the Area of
Interest/Medical Device or Technology
(identified in table 1or 2) that the visit
will demonstrate to CDRH staff.
ADDRESSES: Submit either electronic
requests to https://www.regulations.gov
or written requests to the Division of
Dockets Management (HFA–305), Food
and Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville MD 20852.
Identify comments with the docket
number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT:
Latonya Powell, Center for Devices and
Radiological Health, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 4448, Silver Spring,
MD 20993–0002, 301–796–6965, FAX:
301–827–3079,
Latonya.powell@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
CDRH launched the ELP Pilot in 2012
and will fully implement the program in
2013. The Center is responsible for
ensuring the safety and effectiveness of
medical devices marketed in the United
States. Furthermore, CDRH assures that
patients and providers have timely and
continued access to safe, effective, highquality medical devices and safe
radiation-emitting products. In support
of this mission, the Center launched
various training and development
initiatives to enhance performance of its
regulatory review staff and other staff
involved in the premarket review
process. CDRH is driven to advance
regulatory science; provide industry
with predictable, consistent,
transparent, and efficient regulatory
pathways; and assure consumer
E:\FR\FM\02APN1.SGM
02APN1
]]>Agencies
[Federal Register Volume 78, Number 63 (Tuesday, April 2, 2013)]
[Notices]
[Page 19711]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-07582]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 78 FR 5812, dated January 28, 2013) is amended
to reflect the reorganization of the Office for State, Tribal, Local,
and Territorial Support.
Section C-B, Organization and Functions, is hereby amended as
follows:
Delete in its entirety the title and function statements for the
Knowledge Management Office (CQA5), Office of the Director (CQA).
Revise the functional statement for the Public Health Law Office
(CQA2), Office of the Director (CQA) as follows:
After item (8), insert the following: (9) establish collaboration
and coordination between clinical medicine and public health to better
coordinate and partner for healthier communities.
Dated: March 22, 2013.
Sherri A. Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2013-07582 Filed 4-1-13; 8:45 am]
BILLING CODE 4160-18-M
